It is news that gives hope to over two million people with corona infection worldwide.
In a Chicago hospital, Covid-19 patients respond positively to an antiviral drug as part of a study. According to a report by the US health portal “STAT”, fever and breathing difficulties decreased, almost all patients were discharged within less than a week.
The drug Remdesivir from the California pharmaceutical company Gilead Sciences is one of the first drugs that have been proven to affect the coronavirus. It could be the first approved drug for lung disease Covid-19.
The University of Chicago recruited 125 corona patients for the study. 113 of them were seriously ill. All patients were treated with daily remedesivir infusions. A full study has not yet been published.
“The best news is that most of our patients have already been discharged, which is great,” quotes online infection infection specialist Kathleen Mullane of the University of Chicago from a video discussion the magazine got.
“STAT” contacted Mullane. This confirmed the existence of the video, but did not want to comment further. No Gilead study has been published yet, but expectations are high.
In a statement by the pharmaceutical company: “What we can say so far is that we are waiting for data from ongoing studies.”
Remdesivir is an active ingredient that was developed in the fight against Ebola, among other things.
– .
